Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy.
Pandya P, Vendetti FP, El-Ghoubaira J, Pathak S, Deppas JJ, Jones R, Columbus AV, Zhang Y, Ivanov D, Huang Z, MacDonald KM, Harding SM, Buj R, Aird KM, Beumer JH, Sobol RW, Bakkenist CJ.
Pandya P, et al. Among authors: macdonald km.
bioRxiv [Preprint]. 2024 Apr 5:2024.04.04.588079. doi: 10.1101/2024.04.04.588079.
bioRxiv. 2024.
PMID: 38883769
Free PMC article.
Preprint.